Dr Kimberley Smith, Assessing risk for type 2 diabetes using UK Biobank
Dr Deborah Thompson, Validating risk prediction models for common hormonal cancers
Dr Ahmad Hariri, GWAS of Threat-Related Amygdala Reactivity
Dr Michael Blum, Evaluation of statistical learning to compute polygenic risk scores.
Dr Laura Gray, Using the UK Biobank to validate and refine two diabetes risk prediction tools
Dr Loes Rutten-Jacobs: Role of vascular risk factors, genes and lifestyle in the risk of cerebrovascular disease, cognitive decline and dementia.
Dr. Kathleen Egan, Moffitt Cancer Center, United States
Professor Kenneth Muir, University of Manchester
Professor Montserrat Garcia-Closas, Institute of Cancer Research, Sutton